AKTX
Akari Therapeutics
AKTX
AKTX
8 hedge funds and large institutions have $326K invested in Akari Therapeutics in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Renaissance Technologies
New York
|
+$8.53K |
Top Sellers
1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$215K |
2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$22 |
3 |
Morgan Stanley
New York
|
-$18 |